Open access peer-reviewed Edited Volume

Melanoma

Current Clinical Management and Future Therapeutics

Edited by Mandi Murph

University of Georgia, United States of America

Melanoma - Current Clinical Management and Future Therapeutics serves as an advanced course in melanoma or an addendum to further polish expertise. Sections of the book include a thorough introduction on epidemiology and disease, the current surgical management of melanoma and lymph node dissection, immunotherapy along with drug toxicities and emerging research topics, like RAGE and autotaxin, that have potential therapeutic applications. The chapters in this book explore the most common subtype of melanoma, cutaneous disease, as well as a rare form, acral lentiginous melanoma and even canine tumors. Experts from around the globe contributed chapters, most of which have visual illustrations to depict aspects of disease management and therapy, allowing readers to grasp the advanced concepts presented.

Read more >Order hardcopy
IntechOpen
MelanomaCurrent Clinical Management and Future TherapeuticsEdited by Mandi Murph

Published: April 1st 2015

DOI: 10.5772/58516

ISBN: 978-953-51-2036-0

Copyright year: 2015

Books open for chapter submissions

14120 Total Chapter Downloads

6 Crossref Citations

4 Web of Science Citations

11 Dimensions Citations

chaptersDownloads

Open access peer-reviewed

1. Melanoma — Epidemiology, Risk Factors, and the Role of Adaptive Pigmentation

By Erin M. Wolf Horrell, Kalin Wilson and John A. D’Orazio

1219

Open access peer-reviewed

2. Acral Melanoma — A Distinct Molecular and Clinical Subtype

By R. Barra-Martínez, N.E. Herrera-González, F. Fernández –Ramírez and L.A. Torres

927

Open access peer-reviewed

3. Signaling Pathways Altered During the Metastatic Progression of Melanoma

By Ana Carolina Monteiro, Mariana Toricelli and Miriam Galvonas Jasiulionis

952

Open access peer-reviewed

4. Surgery and Staging of Melanoma

By Rolland Gyulai, Zsolt Kádár and Zsuzsanna Lengyel

1378

Open access peer-reviewed

5. Current Surgical Management of Acral Lentiginous Melanoma

By Yasuhiro Nakamura, Yukiko Teramoto, Sayuri Sato and Akifumi Yamamoto

1250

Open access peer-reviewed

6. Changing Perceptions of Lymphadenectomy and Sentinel Lymph Node Biopsy in Melanoma

By Antonio Sommariva, Camilla Cona and Carlo Riccardo Rossi

959

Open access peer-reviewed

7. Current Insights Into Canine Cutaneous Melanocytic Tumours Diagnosis

By Luis Resende, Joana Moreira, Justina Prada, Felisbina Luisa Queiroga and Isabel Pires

1509

Open access peer-reviewed

8. Emerging Drug Combination Approaches in Melanoma Therapy

By Jin Wang, Duane D. Miller and Wei Li

939

Open access peer-reviewed

9. New Insights in Cutaneous Melanoma Immune-Therapy — Tackling Immune-Suppression and Specific Anti-Tumoral Response

By Monica Neagu and Carolina Constantin

719

Open access peer-reviewed

10. Can Redirected T Cells Outsmart Aggressive Melanoma? The Promise and Challenge of Adoptive Cell Therapy

By Jennifer Makalowski and Hinrich Abken

868

Open access peer-reviewed

11. Toxicities of New Drugs for Melanoma Treatment and their Management

By Paola Savoia and Paolo Fava

829

Open access peer-reviewed

12. Autotaxin – An Enzymatic Augmenter of Malignant Progression Linked to Inflammation

By David N. Brindley, Matthew G.K. Benesch and Mandi M. Murph

969

Open access peer-reviewed

13. RAGE and Its Ligands in Melanoma

By Estelle Leclerc

856

Open access peer-reviewed

14. Gangliosides and Antigangliosides in Malignant Melanoma

By Corina-Daniela Ene (Nicolae) and Ilinca Nicolae

746

Edited Volume and chapters are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Edited Volume

Free shipping with DHL Express

Hardcover (ex. VAT)£170

Order now

Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase